Search company, investor...

Adenosine Therapeutics

adenrx.com

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$15M

Valuation

$0000 

Revenue

$0000 

About Adenosine Therapeutics

Adenosine Therapeutics develops pharmaceuticals related to the biochemical compound adenosine.

Headquarters Location

310 4th Street NE Court Square Building Suite 201

Charlottesville, Virginia, 22905,

United States

434-220-9400

Missing: Adenosine Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Adenosine Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Adenosine Therapeutics Patents

Adenosine Therapeutics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/14/2012

1/31/2017

Medical imaging, 2d nuclear medical imaging, Radiopharmaceuticals, Medical physics, 3d nuclear medical imaging

Grant

Application Date

9/14/2012

Grant Date

1/31/2017

Title

Related Topics

Medical imaging, 2d nuclear medical imaging, Radiopharmaceuticals, Medical physics, 3d nuclear medical imaging

Status

Grant

Adenosine Therapeutics Frequently Asked Questions (FAQ)

  • When was Adenosine Therapeutics founded?

    Adenosine Therapeutics was founded in 1999.

  • Where is Adenosine Therapeutics's headquarters?

    Adenosine Therapeutics's headquarters is located at 310 4th Street NE, Charlottesville.

  • What is Adenosine Therapeutics's latest funding round?

    Adenosine Therapeutics's latest funding round is Acquired.

  • How much did Adenosine Therapeutics raise?

    Adenosine Therapeutics raised a total of $15M.

  • Who are the investors of Adenosine Therapeutics?

    Investors of Adenosine Therapeutics include PGxHealth, Novartis Venture Funds, Emerging Technology Center, Quadrant Venture Capital, ATEL Ventures and 3 more.

  • Who are Adenosine Therapeutics's competitors?

    Competitors of Adenosine Therapeutics include numares, Concert Pharmaceuticals, Banyan Biomarkers, Stemina Biomarker Discovery, Adastra Pharmaceuticals and 12 more.

Compare Adenosine Therapeutics to Competitors

T
Total Pharmaceutical Care

Total Pharmaceutical Care, Inc. offers home healthcare and infusion therapy services

P
PhysioGenix

PhysioGenix offers pharmacogenetics and physiological genetics products and services

n
numares

numares, formerly LipoFIT Analytic, is a specialized developer and provider of analytic and diagnostic test systems based on nuclear magnetic resonance (NMR) spectroscopy and numares' proprietary Magnetic Group Signaling (MGS) technology. numares HEALTH develops and markets in-vitro diagnostic tests with the CE-marking and integrated test systems for high-throughput use in clinical diagnostics and life science research. The highly standardized tests provide valuable information on the disease status of patients in the indication areas of cardiovascular disease, nephrology and oncology. In addition, numares HEALTH provides its test systems to the pharmaceutical industry on a fee-for-service basis. They can be used for example to investigate the therapeutic effects of medication as part of clinical trials. Furthermore, the company supports customers with complex issues and clinical trials, drawing on its many years of expertise and experience in the area of NMR spectroscopy and metabolomics.

A
Adastra Pharmaceuticals

Adastra Pharmaceuticals is a private, clinical-stage biopharmaceutical company committed to providing responsible solutions to advance patient care in oncology. Its vision is to identify, develop, and deliver to patients important new therapies for diseases with significant unmet needs. This commitment is epitomized by its lead clinical candidate, zotiraciclib, which is initially being developed for the treatment of high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG), two forms of brain cancer characterized by Myc overexpression. Adastra possesses a rich history of institutional and academic collaboration, including ongoing clinical research programs with the National Cancer Institute (NCI) and the European Organisation for Research and Treatment of Cancer (EORTC).

E
Euroflow

Euroflow develop technologies, products and services for the development and production of new therapeutic drugs based on chromatographic techniques, with the aim of bringing new products to market quickly.

Chiral Technologies Logo
Chiral Technologies

Welcome to CHIRAL TECHNOLOGIES, INC., a supplier of columns, bulk stationary phases and separation services for chromatographic enantioselective separations to pharmaceutical, biotechnology, and fine chemicals companies. As users explore the company's site users will find many ways in which having CHIRAL TECHNOLOGIES as their partner can help users in all aspects of chromatographic resolution.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.